Related Experiment Video
Updated: Jul 7, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Psoriasis comorbid with atherosclerosis meets in lipid metabolism
Liuping Chen1, Huiqi Chen2,3, Sien Guo2,3
1Department of Critical Care Medicine, The Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Insights
Psoriasis (PSO) and atherosclerosis (AS) are linked, with lipid metabolism disorders increasingly recognized as a key factor. This review explores their connection, risk factors, and treatments.
Area of Science:
- Dermatology and Cardiology
- Metabolic research
Background:
- Psoriasis (PSO) affects 1%-3% of the population, with rising incidence.
- PSO significantly increases cardiovascular disease risk, notably atherosclerosis (AS).
- Emerging evidence links lipid metabolism disorders to PSO-AS comorbidity.
Purpose of the Study:
- To review epidemiological data, clinical treatments, risk factors, and lipid metabolism in PSO-AS.
- To highlight the role of lipid metabolism in the PSO-AS connection.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of clinical treatment strategies.
- Examination of risk factors and lipid profiles.
Main Results:
- Inflammation was a traditional view, but lipid metabolism is now a key focus.
- Disordered lipid metabolism is increasingly implicated in AS development in PSO patients.
Conclusions:
- Lipid metabolism is crucial in understanding the link between psoriasis and atherosclerosis.
- Further research into lipid pathways may offer novel therapeutic targets.
Abstract:
Psoriasis (PSO) is a common skin disease affecting approximately 1%-3% of the population, and the incidence rate is increasing yearly. PSO is associated with a dramatically increased risk of cardiovascular disease, the most common of which is atherosclerosis (AS). In the past, inflammation was considered to be the triggering factor of the two comorbidities, but in recent years, studies have found that lipid metabolism disorders increase the probability of atherosclerosis in patients with psoriasis. In this review, we discuss epidemiological studies, clinical treatment methods, risk factors, and lipid metabolism of psoriasis and atherosclerosis comorbidities.
Related Concept Videos
Inflammation
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

